Overview
First FDA-authorized autonomous AI for diabetic retinopathy detection.
Details
LumineticsCore (IDx-DR) is FDA De Novo authorized for autonomous diabetic retinopathy detection in primary care without specialist review.
IDx-DR (Digital Diagnostics)
First FDA-authorized autonomous AI for diabetic retinopathy detection. LumineticsCore (IDx-DR) is FDA De Novo authorized for autonomous diabetic retinopathy detection in primary care without specialist review.